← FDA DRUG APPROVALS

FDA ANDA · ANDA085027

HYDROCORTISONE

Sponsor: PADAGIS US

APPLICATION
ANDA085027
TYPE
ANDA
ORIGINAL APPROVAL
1977-11-30
LATEST ACTION
2000-01-03
ROUTE
TOPICAL
DOSAGE FORM
OINTMENT
MARKETING STATUS
Prescription

Products

HYDROCORTISONEPrescription
HYDROCORTISONE 2.5% · OINTMENT · TOPICAL

Approval history

2000-01-03Manufacturing (CMC) · Supplement 21AP
1999-08-18Manufacturing (CMC) · Supplement 19AP
1999-08-18Manufacturing (CMC) · Supplement 18AP
1999-08-18Labeling · Supplement 20AP
1996-06-18Labeling · Supplement 17AP
1989-08-14Labeling · Supplement 16AP
1986-06-11Manufacturing (CMC) · Supplement 13AP
1982-07-07Manufacturing (CMC) · Supplement 8AP
1982-06-02Manufacturing (CMC) · Supplement 9AP
1977-11-30OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →